If you have spent any time researching silver supplements, you have probably noticed that the marketing language across the category sounds almost identical. Every brand claims to be "the most pure," "the most bioavailable," or "the most studied." It is hard to know what is real science and what is marketing copy in a science costume.

I have spent more than two decades working with silver compounds, and I want to walk you through what makes SilverSol® Technology — the molecule used in every Silver Biotics product — different from generic colloidal silver. Not the marketing version. The actual chemistry, the research behind it, and the engineering decisions that went into building it.

This is a long read. If you only have a minute, here is the summary: SilverSol® is a patented multivalent silver compound (Ag₄O₄) in which silver atoms are permanently bonded to oxygen at the molecular level. That structural difference, more than anything else, is what separates it from the rest of the colloidal silver category — and it is the reason SilverSol® has been the subject of over 400 published studies and 45+ patents worldwide.

If you have a few more minutes, the rest of this post walks through how it was developed, what is happening at the molecular level, and what the research actually shows.

The 30-Year Story of How SilverSol® Was Developed

The earliest work on what would become SilverSol® began in the 1990s when our co-founder Bill Moeller, along with chemist and electrical engineer Robert Holladay, set out to solve a problem the colloidal silver category had been struggling with for a century: inconsistency.

Silver as a healing agent goes back at least 2,000 years. The Romans stored water in silver vessels. World War I medics packed wounds with silver leaf. Even modern hospital burn dressings use silver-impregnated materials. But somewhere in the middle of the twentieth century, with the arrival of antibiotics, silver fell out of mainstream medicine — and the category that survived was a patchwork of inconsistent homemade and small-batch products marketed as "colloidal silver."

The problem with traditional colloidal silver is in the word itself. A "colloid" is a suspension — particles of one material floating in another. In colloidal silver, microscopic silver particles are suspended in water, held apart by their electrical charge. The challenge with a suspension is that over time the particles can clump, settle, or grow in size, which changes the behavior of the product. That is why two bottles of colloidal silver labeled "10 ppm" can be very different products.

Bill and Robert were not satisfied with that. Their goal was to engineer a silver compound that did not depend on suspension at all — one where the silver was permanently bonded into a stable molecular structure, with a predictable particle size and a research-grade consistency from batch to batch. That work took the better part of a decade. The result, patented in the early 2000s, was SilverSol® Technology.

American Biotech Labs was founded in 1998 to bring the technology out of the lab and into consumer health products. Silver Biotics is the consumer brand built on that foundation.

What "Multivalent" Means and Why It Matters

The single most important thing to understand about SilverSol® is the word multivalent. It sounds technical, but it describes something very specific about how the molecule interacts with the world around it.

In chemistry, valence is the number of electrons an atom can give up or accept in a reaction. Standard ionic silver (Ag⁺) is monovalent — it can give up one electron at a time. That is how it works against microbes: it donates a single electron, which disrupts cellular processes in bacteria, viruses, or fungi.

SilverSol® is multivalent because of how the silver atoms are arranged in the Ag₄O₄ structure. Four silver atoms are bonded to four oxygen atoms in a tetrahedral configuration, and that configuration allows the molecule to donate multiple electrons at the same time. In practical terms, multivalency translates to multiple modes of action: SilverSol® has been studied for the ability to disrupt microbial cell walls, interfere with cellular respiration, and bind to microbial DNA — all simultaneously.

This matters because microbes are good at developing resistance to single-mechanism attacks. A drug that works through one pathway can be defeated when the microbe evolves to neutralize that pathway. A molecule that works through multiple pathways at once is much harder to develop resistance against, which is part of what attracted the original research interest in SilverSol® for antibiotic-resistant infections (see our Research page for the full library of published studies).

Inside the Ag₄O₄ Structure: Bonded Silver vs Suspended Particles

If you took a drop of generic colloidal silver and looked at it under an electron microscope, you would see individual silver particles floating in water — some larger, some smaller, with the smallest ones often less stable than the larger ones. The particles are held in suspension by their electrical charge, and they can come out of suspension over time.

If you took a drop of SilverSol® and looked at it under the same microscope, you would see something different. The silver and oxygen atoms are bonded together into discrete tetrahedral molecules, with each molecule the same shape and size as the next. The bonded molecules do not depend on suspension to stay distributed — they are chemically bound to the surrounding water at the molecular level.

That structural difference produces three downstream consequences:

• The product does not settle or separate. A bottle of SilverSol® stored for two years has the same particle distribution as a bottle bottled yesterday.
• The particle size is engineered, not random. SilverSol® particles measure 5 to 7 nanometers consistently. Generic colloidal silver products in independent lab analyses have shown particle sizes ranging from less than 1 nanometer to over 100 nanometers in the same product category.
• The chemistry stays consistent from batch to batch. Because the silver is bonded rather than suspended, the manufacturing process produces molecules with a known structure, not particles that vary based on production conditions.

Particle Size, Consistency, and Bioavailability

Particle size matters in silver chemistry because surface area drives reactivity. A smaller particle has more surface area per gram of silver than a larger particle — and the surface is where the chemistry happens.

SilverSol® particles measure 5 to 7 nanometers. To put that in context, a single nanometer is one billionth of a meter. A human hair is roughly 80,000 to 100,000 nanometers thick. At the 5–7 nanometer scale, the molecules are small enough to interact at the cellular level but large enough to remain stable in the bonded molecular structure.

Bioavailability — the share of a substance the body can actually absorb and use — is influenced by particle size, structure, and how easily the substance moves through biological membranes. Independent studies on SilverSol® have reported bioavailability above 99%, meaning nearly all of the silver in a dose is absorbed and used by the body before being cleared.

The clearance side of that equation matters as much as the absorption side. SilverSol® is engineered to be cleared from the body within 24 to 72 hours of ingestion, primarily through normal kidney and digestive function. That clearance profile is part of why the molecule does not accumulate in tissues at recommended doses, a topic we cover in more detail in our companion post, Is Colloidal Silver Safe?

The Patent Portfolio: 45+ Patents Worldwide

Patents are not the same as proof, but they are an indicator of novelty. A patent office only grants a patent when an inventor demonstrates that the underlying technology is meaningfully different from what existed before.

The SilverSol® patent portfolio currently includes more than 45 patents worldwide, covering the underlying molecular structure, the manufacturing process, and a wide range of applications across health, wound care, oral care, and skin care. The patents are held by American Biotech Labs and cover the United States (searchable through the USPTO), the European Union, and several other jurisdictions.

If a competing product is marketed as "colloidal silver" without referencing these patents — or without licensing the technology — it is not SilverSol®. It is a different product, made by a different process, with different chemistry.

The Research Footprint: 400+ Peer-Reviewed Studies

The single most distinguishing feature of SilverSol® is the research footprint. As of 2026, more than 400 published studies investigate the SilverSol® molecule specifically — not "silver" generically, but the patented Ag₄O₄ compound used in Silver Biotics products.

That research spans several categories:

• Antimicrobial studies: investigating SilverSol®'s activity against bacteria, viruses, and fungi, including antibiotic-resistant strains. One of the more cited papers, published on PMC in 2024, examined SilverSol®'s effect on antibiotic-resistant Staphylococcus aureus and detailed the multiple physiological mechanisms involved.
• Wound healing studies: examining the use of silver-based gels in supporting the natural healing process of cuts, scrapes, burns, and surgical sites.
• Safety studies: including FDA-cleared safety studies that characterize the dose-response profile and clearance kinetics of the molecule.
• Microbiome studies: investigating the molecule's selectivity — its tendency to act against harmful microbes while leaving beneficial bacteria largely intact.
• Application-specific studies: oral health, dermatology, ophthalmology, and veterinary applications.

The full citation library is maintained on the Silver Biotics Research page, with links to PubMed and PMC where the papers are indexed. We update it as new research is published.

Most colloidal silver products on the market do not have brand-specific peer-reviewed research behind them. They cite studies on "silver" in general — which is a category-level claim, not a product-specific one. To compare two silver products honestly, you have to compare the research on the actual molecules in each bottle, not the research on the broader category.

How SilverSol® Behaves in the Body

The body is not a passive container. When you take any substance orally, what matters is not just what is in the bottle but what happens after it is swallowed: how it is absorbed, where it is distributed, how it is used, and how it is cleared.

SilverSol®'s behavior in the body has been characterized in published research, and here is the general profile:

Absorption — at the 5–7 nm bonded molecular size, SilverSol® is absorbed across the gut wall efficiently. Reported bioavailability is above 99%, meaning the dose taken is closely tied to the dose absorbed.

Distribution — once absorbed, the molecule circulates through the bloodstream and reaches tissues throughout the body. Because of the multivalent structure, SilverSol® is reactive against microbes wherever it encounters them.

Activity — the multivalent mechanism gives SilverSol® multiple modes of action simultaneously, which has been studied across antimicrobial, antiviral, and antifungal applications. Importantly, the research also suggests selectivity: SilverSol® has been studied for its ability to act against pathogenic microbes while leaving beneficial gut flora largely undisturbed.

Clearance — within 24 to 72 hours, the molecule is cleared from the body through normal kidney and digestive function. This clearance profile is part of why SilverSol® does not accumulate in tissues at recommended doses, which is the mechanism behind the safety record covered in our safety post.

Why "Probiotic-Friendly" Silver Is a Different Category

One of the standard concerns about any antimicrobial product taken internally is the question of selectivity. If a substance kills harmful microbes, does it also kill the beneficial ones — the gut microbiome that does so much of the body's day-to-day work?

Generic colloidal silver, particularly older formulations with larger and less-uniform particles, has been associated with non-selective antimicrobial action. That is part of why many holistic practitioners recommend pairing silver with a probiotic.

SilverSol® has been studied specifically for its effect on the gut microbiome, and the published data suggests a meaningful degree of selectivity. The bonded molecular structure and the multivalent mechanism appear to be more disruptive to pathogenic microbes than to commensal gut bacteria, which is the reason we describe SilverSol® as probiotic-friendly.

This is not a license to be reckless. If you are working through a course of antibiotics or rebuilding a depleted microbiome after illness, talking to your healthcare provider about timing and dosing remains the right move. But for daily-use immune support, probiotic-friendly is a different category from older non-selective silver products.

Stability Across Heat, Cold, and Time

Most colloidal silver products require careful handling. Manufacturers recommend dark glass bottles, cool storage conditions, and reasonably short shelf lives because suspension-based products are sensitive to light, heat, and time. Over a long enough timeline, particles can clump, settle, or change in ways that affect the product's behavior.

SilverSol® is stable across a wider range of conditions because the molecule does not depend on suspension. The Ag₄O₄ structure is held together by chemical bonds, which means temperature variation does not break the molecule down the way it would compromise a colloidal suspension. SilverSol® has been tested through freezing and high heat without measurable degradation.

That stability is the reason SilverSol® can be formulated into products that traditional colloidal silver cannot survive in:

• Toothpaste — formulations like our Fluoride-Free Hydroxyapatite Toothpaste need the silver compound to remain stable in a tube with abrasives, flavoring agents, and humectants over a multi-year shelf life.
• Gels and creams — products like the Silver Gel and Advanced Healing Skin Cream require the silver to stay active in the gel or emulsion matrix without separating out.
• Lozenges — the Silver Lozenges are pressed and heat-set; the silver compound has to survive that manufacturing process.
• Sprays and rinses — the Sinus Rinse and oral spray products use aerosolized formulations that depend on a stable underlying compound.

If silver was unstable enough to fall out of suspension in a bottle of liquid, none of these formats would work. The fact that the SilverSol® product line covers so many formats is, indirectly, evidence of the underlying stability.

Frequently Asked Questions

Is SilverSol® the same as colloidal silver?

No. SilverSol® is a patented multivalent silver compound (Ag₄O₄) in which silver atoms are bonded to oxygen at the molecular level. "Colloidal silver" is a generic category of products that suspend silver particles in water without the bonded structure. The two have different chemistry, different stability profiles, and different research footprints. Our companion post SilverSol vs Colloidal Silver: 7 Differences That Matter walks through the full comparison.

What does the "Ag₄O₄" notation mean?

It is the molecular formula. Each SilverSol® molecule contains four silver atoms (Ag) bonded to four oxygen atoms (O) in a tetrahedral arrangement. The notation is the standard chemistry way of describing the molecule's composition.

How long has SilverSol® been on the market?

The underlying research began in the 1990s and the company was founded in 1998. The technology has been in continuous use in consumer health products for over 25 years.

Where is SilverSol® manufactured?

All SilverSol® products are manufactured in our FDA-registered, cGMP-audited facility in American Fork, Utah. The facility is audited annually.

What does the FDA say about SilverSol®?

SilverSol® is sold as a dietary supplement (in the liquid and lozenge formats) and as a wound dressing (in the gel formats). The FDA does not "approve" dietary supplements in the way it approves drugs, but it does regulate them through labeling and manufacturing standards (which we meet through our cGMP-audited facility). The FDA disclaimer that appears on our products — "These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease" — is the standard supplement disclaimer required under the Dietary Supplement Health and Education Act for all products in this category.

Is SilverSol® safe to take every day?

SilverSol® has a 25+ year safety record at recommended doses. The bonded molecular structure and rapid clearance profile (24–72 hours) are the mechanisms that distinguish its safety profile from older colloidal silver products. Stay within label recommendations, and consult your healthcare provider if you have specific medical conditions or are taking medications.

Where can I read the research?

The full citation library is maintained on the Silver Biotics Research page. Many of the studies are also indexed on PubMed and PMC, where you can read the full papers or the abstracts.